Renaissance Technologies’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.3M Buy
4,194,427
+188,600
+5% +$687K 0.02% 838
2025
Q1
$7.69M Buy
4,005,827
+182,300
+5% +$350K 0.01% 1156
2024
Q4
$7.26M Buy
3,823,527
+105,727
+3% +$201K 0.01% 1208
2024
Q3
$4.91M Sell
3,717,800
-197,000
-5% -$260K 0.01% 1454
2024
Q2
$3.99M Buy
3,914,800
+262,700
+7% +$268K 0.01% 1452
2024
Q1
$6.68M Sell
3,652,100
-1,127,283
-24% -$2.06M 0.01% 1228
2023
Q4
$5.93M Buy
4,779,383
+1,623,956
+51% +$2.01M 0.01% 1243
2023
Q3
$3.6M Sell
3,155,427
-175,300
-5% -$200K 0.01% 1485
2023
Q2
$3.05M Buy
3,330,727
+992,227
+42% +$908K ﹤0.01% 1732
2023
Q1
$1.31M Sell
2,338,500
-547,727
-19% -$307K ﹤0.01% 2290
2022
Q4
$1.67M Sell
2,886,227
-130,200
-4% -$75.1K ﹤0.01% 2193
2022
Q3
$954K Buy
3,016,427
+1,534,127
+103% +$485K ﹤0.01% 2527
2022
Q2
$523K Buy
1,482,300
+478,973
+48% +$169K ﹤0.01% 3139
2022
Q1
$720K Buy
1,003,327
+380,300
+61% +$273K ﹤0.01% 2949
2021
Q4
$1.41M Sell
623,027
-326,900
-34% -$739K ﹤0.01% 2412
2021
Q3
$2.74M Sell
949,927
-877,803
-48% -$2.53M ﹤0.01% 1862
2021
Q2
$6.93M Buy
1,827,730
+757,149
+71% +$2.87M 0.01% 1428
2021
Q1
$3.62M Sell
1,070,581
-377,346
-26% -$1.28M ﹤0.01% 1847
2020
Q4
$4.05M Buy
1,447,927
+1,377,752
+1,963% +$3.86M ﹤0.01% 1721
2020
Q3
$176K Sell
70,175
-5,514
-7% -$13.8K ﹤0.01% 3133
2020
Q2
$1.03M Buy
+75,689
New +$1.03M ﹤0.01% 2522
2020
Q1
Sell
-138,527
Closed -$875K 3415
2019
Q4
$875K Buy
138,527
+95,100
+219% +$601K ﹤0.01% 2691
2019
Q3
$170K Buy
+43,427
New +$170K ﹤0.01% 3184
2018
Q4
Sell
-1,776,971
Closed -$15.7M 3355
2018
Q3
$15.7M Sell
1,776,971
-97,629
-5% -$862K 0.02% 1078
2018
Q2
$18.7M Sell
1,874,600
-644,500
-26% -$6.43M 0.02% 961
2018
Q1
$24M Buy
2,519,100
+697,900
+38% +$6.65M 0.03% 835
2017
Q4
$27.1M Buy
1,821,200
+400,300
+28% +$5.95M 0.03% 753
2017
Q3
$27.9M Buy
1,420,900
+395,600
+39% +$7.78M 0.03% 696
2017
Q2
$14.7M Buy
1,025,300
+639,033
+165% +$9.18M 0.02% 1023
2017
Q1
$3.55M Buy
386,267
+177,667
+85% +$1.63M 0.01% 1912
2016
Q4
$2.17M Buy
208,600
+56,800
+37% +$591K ﹤0.01% 2183
2016
Q3
$1.37M Buy
151,800
+127,500
+525% +$1.15M ﹤0.01% 2410
2016
Q2
$182K Sell
24,300
-4,200
-15% -$31.5K ﹤0.01% 3070
2016
Q1
$257K Sell
28,500
-80,700
-74% -$728K ﹤0.01% 3017
2015
Q4
$1.41M Sell
109,200
-1,500
-1% -$19.4K ﹤0.01% 2303
2015
Q3
$1.07M Sell
110,700
-270,539
-71% -$2.61M ﹤0.01% 2344
2015
Q2
$3.92M Buy
+381,239
New +$3.92M 0.01% 1605